Molecular Identification and Susceptibility of Clinically Relevant Scedosporium spp. in China

Abstract EN

As various new sibling species within the Scedosporium spp.

have been described recently, this study was conducted to investigate distribution and antifungal susceptibility profiles of the different species of Scedosporium spp.

in China.

Twenty-one clinical strains of Scedosporium from China and two strains from Japan were reidentified by MLSA.

The analysis included BT2, CAL, RPB, SOD, and ACT and the combination of the five loci.

Pseudallescheria boydii complex (17 strains) and S.

apiospermum (6 strains) were identified.

P.

boydii complex included four closely related subgroups: P.

boydii (9 strains), P.

ellipsoidea (6 strains), P.

fusoidea (1 strain), and P.

angusta (1 strain).

There were no significant differences in MICs for neither VOR, POS, nor AMB over all the five species in study.

For itraconazole, intraspecific diversity was evident.